Nausea and emesis: Still an unsolved problem in cancer patients?

Supportive Care in Cancer

Volumn 10, Issue 2, 2002, Pages 85-87

  Herrstedt, Jørn ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANESTHETIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CISPLATIN; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOPAMINE RECEPTOR BLOCKING AGENT; DOXORUBICIN; FABESETRON; FENCLONINE; HALOPERIDOL; METHOTREXATE; METOCLOPRAMIDE; METOPIMAZINE; ONDANSETRON; OPIATE; PROPOFOL; RESERPINE; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN ANTAGONIST; TACHYKININ RECEPTOR ANTAGONIST; TROPISETRON;

CANCER CHEMOTHERAPY; CANCER PATIENT; CHEMOTHERAPY INDUCED EMESIS; DRUG EFFICACY; EDITORIAL; GASTROINTESTINAL MOTILITY; HUMAN; INTESTINE MUCOSA PERMEABILITY; LOW DRUG DOSE; NAUSEA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; HUMANS; NAUSEA; NEOPLASMS; TREATMENT OUTCOME; VOMITING;

EID: 0036933217     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-001-0339-7     Document Type: Editorial

References (21)

1. Wilcox PM, Fetting JH, Nettesheim KM, Abeloff MD (1982) Anticipatory vomiting in women receiving cyclophosphamide, methotrexate and 5-fluorouracil (CMF) adjuvant chemotherapy for breast cancer. Cancer Treat Rep 66:1601-1604
2. Roila F, Donati D, Tamberi S, Margutti G (2002) Delayed emesis: incidence, pattern, prognostic factors and optimal treatment. Support Care Cancer 10: (this issue)
3. Aapro MS (2002) How do we manage patients with refractory or breakthrough emesis? Support Care Cancer 10: (this issue)
4. Morrow GR, Roscoe JA, Hickok JT, Andrews PLR, Matteson S (2002) Nausea and emesis: evidence for a biobehavioral perspective. Support Care Cancer 10: (this issue)
5. Molassiotis A, Yam BMC, Yung H, Chan FYS, Mok TSK (2002) Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients. Support Care Cancer 10 (this issue)
6. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC) (1998) Prevention of chemotherapy- and radiotherapy-induced emesis: results of the Perugia Consensus Conference. Ann Oncol 9:811-819
7. Gralla RJ, Osoba D, Kris MG, et al (1999) Recommendations for the use of antiemetics: evidence-based clinical practice guidelines. J Clin Oncol 17:2971-2994
8. ESMO Guidelines Task Force (2001) ESMO recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV). Ann Oncol 12:1059-1060
9. Holzer P, Schluet W, Maggi CA (1995) Substance P stimulates and inhibits peristalsis via distinct receptors. J Pharmacol Exp Ther 274:322-328
10. Campos D, Pereira JR, Reinhardt RR, et al (2001) Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist MK-0869, in combination with granisetron and dexamethasone or with dexamethasone alone. J Clin Oncol 19:1759-1767
11. Fredrikson M, Hursti TJ, Steineck G, Fürst CJ, Börjesson S, Peterson C (1994) Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline. Br J Cancer 70:642-645
12. Tanihata S, Igarashi H, Suzuki M, Uchiyama T (2000) Cisplatin-induced early and delayed emesis in the pigeon. Br J Pharmacol 130:132-138
13. 4 receptor in methotrexate-induced delayed emesis in dogs. J Pharmacol Exp Ther 292:1002-1007
14. Roscoe JA, Morrow GR, Hickok JT, Stern RM (2000) Nausea and vomiting remain a significant clinical problem. Trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. J Pain Symptom Manage 20:113-121
15. Osoba D, Zee B, Pater J, et al (1997) Determinants of postchemotherapy nausea and vomiting in patients with cancer. J Clin Oncol 15:116-123
16. De Wit R, Van den Berg H, Burghouts J, et al (1998) Initial high anti-emetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles. Br J Cancer 77:1487-1491
17. Sigsgaard T, Herrstedt J, Handberg J, Kjær M, Dombemowsky P (2001) Ondansetron plus metopimazine compared with ondansetron plus metopimazine plus prednisolone as antiemetic prophylaxis in patients receiving multiple cycles of moderately emetogenic chemotherapy. J Clin Oncol 19:2091-2097
18. Italian Group for Antiemetic Research (1995) Dexamethasone, granisetron or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 332:1-5
19. Tsukuda M, Furukawa S, Kokatsu T, Enomoto H, Kubota A, Furukawa M (1995) Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for prophylactic treatment of emesis induced by cisplatin chemotherapy. Eur J Cancer [A] 31:1647-1649
20. Lee C-W, Suh C-W, Lee J-S, et al (1994) Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis. J Korean Med Sci 9:369-375
21. Lebeau B, Depierre A, Giovannini M, et al (1997) The efficacy of combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with dual antiemetic treatment in cisplatin-based chemotherapy. Ann Oncol 8:887-892